Melanocortin-4 receptor gene and complications after gastric banding

Obesity Surgery

Volumn 16, Issue 2, 2006, Pages 189-195

  Peterli, Ralph ^a   Peters, Thomas ^b   Von Flüe, Markus ^a   Hoch, Matthias ^c   Eberle, Alex N ^c  

^a Surgical Clinic   (Switzerland)

^b Interdisciplinary Center of Nutritional and Metabolic Diseases   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Binge eating disorder; Complications; Laparoscopic gastric banding; MC4 receptor; Morbid obesity; Mutations

Indexed keywords

ALPHA INTERMEDIN; GENOMIC DNA; LEPTIN; MELANOCORTIN 4 RECEPTOR; PROOPIOMELANOCORTIN;

ADULT; ARTICLE; BINGE EATING DISORDER; CLINICAL ARTICLE; FEMALE; GASTRIC BANDING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; HIGH RISK PATIENT; HUMAN; LAPAROSCOPIC SURGERY; MALE; MORBID OBESITY; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECEPTOR GENE; REOPERATION; SURGICAL PATIENT;

ADOLESCENT; ADULT; AGED; ANASTOMOSIS, ROUX-EN-Y; BODY MASS INDEX; FEMALE; GASTROPLASTY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUTATION; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROGNOSIS; RECEPTOR, MELANOCORTIN, TYPE 4; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 33644507463     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089206775565113     Document Type: Article

References (29)

1. Kral JG. The pathogenesis of obesity: stress and the brain-gut axis. SOARD 2005; 1: 25-34.
2. Seeley RJ, Drazen DL, Clegg DJ. The critical role of the melanocortin system in the control of energy balance. Annu Rev Nutr 2004; 24: 133-49.
3. Ellacott KL, Cone RD. The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Prog Horm Res 2004; 59: 395-408.
4. Eberle AN, Bódi J, Orosz G et al. Antagonist and agonist activities of the mouse agouti protein fragment (91-131) at the melanocortin-1 receptor. J Recept Signal Transduct 2001; 21: 25-45.
5. Coll AP, Farooqi IS, Challis BG et al. Proopiomelanocoitin and energy balance: insights from human and murine genetics. J Clin Endocrinol Metab 2004; 89: 2557-62.
6. Krude H, Biebermann H, Luck W et al Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 2003; 19: 155-7.
7. Krude H, Biebermann H, Schnabel D et al. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 2003; 88: 4633-40.
8. Yeo GS, Farooqi IS, Aminian S et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998; 20: 111-2.
9. Vaisse C, Clement K, Guy-Grand B et al. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998; 20: 113-4.
10. Hinney A, Schmidt A, Nottebom K et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 1999; 84: 1483-6.
11. Farooqi IS, Keogh JM, Yeo GS et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085-95.
12. O'Brian P, Dixon J. Laparoscopic adjustable gastric banding in the treatment of morbid obesity. Arch Surg 2003; 138: 376-82.
13. Peterli R, Donadini A, Peters T et al. Re-operations following laparoscopic adjustable gastric banding. Obes Surg 2002; 12: 851-6.
14. Frigg A, Peterli R, Peters T et al. Reduction in comorbidities 4 years after laparoscopic adjustable gastric banding. Obes Surg 2004; 14: 216-23.
15. Biebermann H, Krude H, Elsner A et al. Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 2003; 52: 2984-88.
16. Potoczna N, Branson R, Kral J et al. Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity. J Gastrointest Surg 2004; 8: 971-81.
17. Wölnerhanssen B, Kern B, Peters T et al. Reduction in slippage with 11-cm Lap-Band® and change of gastric banding technique. Obes Surg 2005; 15: 1050-4.
18. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Washington, D.C.: American Psychiatric Association, 1994.
19. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
20. Farooqi IS, Yeo GS, Keogh JM et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000; 106: 271-9.
21. Branson R, Protoczna N, Krai JG et al. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003; 348: 1096-103.
22. Vaisse C, Clement K, Durand E et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000; 106: 253-62.
23. Duan J, Wainwright MS, Comeron JM et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003; 12: 205-16.
24. Mognol P, Chosidow D, Marmuse J-P. Laparoscopic conversion of laparoscopic gastric banding to Rouxen-Y gastric bypass: a review of 70 patients. Obes Surg 2004; 14: 1349-53.
25. Busetto L, Segato G, DeLuca M et al. Weight loss and postoperative complications in morbidly obese patients with binge eating disorder treated by laparoscopic adjustable gastric banding. Obes Surg 2005; 15: 195-201.
26. Larsen JK, van Ramshorst B, Greenen R et al. Binge eating and its relationship to outcome after laparoscopic adjustable gastric banding. Obes Surg 2004; 14: 1111-7.
27. Kalarchian MA, Marcus MD, Wilson GT et al. Binge eating among gastric bypass patients at long-term follow-up. Obes Surg 2002; 12: 270-5.
28. Weber M, Mueller M, Bucher T et al. Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg 2004; 240: 975-83.
29. Birtho L, Steffen R, Branson R et al. Management of failed adjustable gastric banding. Surgery 2005; 137: 33-41.